Public research preview

Christopher L. Jacobs, Representative disclosure: KalVista Pharmaceuticals, Inc. (KALV)

Disclosed a buy transaction in KalVista Pharmaceuticals, Inc. (KALV). Use this page to inspect source evidence, confidence scores, filing delay, and post-disclosure price movement before deciding whether to research the signal further.

Copy Window
Probablement trop tard
0/100
Qualité du signal
63/100
Qualité des données
93%
Qualité élevée

This public page is for public-disclosure research only. It is not investment advice and does not place orders. Verify the official source before relying on any signal.

Evidence passport

Official-source context and parser confidence before any simulation or alert decision.

Source
House STOCK Act disclosures
Published
20 Jan 2023, 00:00
Parser confidence
94%
Instrument mapping
95%
Filing delay
39 days

Chronologie

Date de transaction

12 Dec 2022

Déclaration publique

20 Jan 2023

Maintenant

Suivi aujourd’hui

Délai de déclaration: 39 jours

Mouvement du cours

Couverture partielle

Fournisseur
Yahoo Finance daily close
Récupéré
9 sept. 2026

Missing Yahoo Finance daily close for transaction date 2022-12-12, disclosure date 2023-01-20.

Parcours du cours

KALV du contexte avant transaction jusqu’à la dernière clôture.

Dernier

12 juin 2026 · 27 USD · N'achèterait pas

Décision du système

N'achèterait pasLes filtres de la stratégie rejettent ce signal. Filtres échoués: Filed within 30 days · Pre-disclosure move <= 35%.

N'achèterait pas27USDDate30 mai11 juin12 juinOfficial disclosure20 janv.Dernier
  • Pas encore public
  • N'achèterait pas
Cours de secours à la transaction
Cours de secours à la déclaration
Dernier cours de secours
Mouvement avant déclaration
Mouvement après déclaration
Mouvement ajusté du marché
1w since disclosure
1m since disclosure
3m since disclosure
Hausse maximale avant déclaration
Repli depuis le pic

Why Copy Window is Probably too late

Supporting factors

  • Parsed buy disclosure for ordinary shares from House STOCK Act disclosures.
  • Reported amount is $1,001 - $15,000.
  • Post-disclosure move is calculated from Yahoo Finance daily close daily closes.

Cautions

  • Yahoo Finance daily close coverage is end-of-day and should be verified against the official price source.
  • Review the original source document before making any investment decision.

Source document

House STOCK Act disclosures, published 20 Jan 2023, 00:00

View source
Parser confidence
94%
Instrument mapping
95%
FieldExtracted value
roleRepresentative
sidebuy
value1001
sourcehouse_stock_act
tickerKALV
chamberHouse
currencyUSD
assetTypestock
sourceUrlhttps://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2023/20022265.pdf
personNameChristopher L. Jacobs
amountRange$1,001 - $15,000
companyNameKalVista Pharmaceuticals, Inc. (KALV)
publishedAt2023-01-20T00:00:00.000Z
rawDocumentIdraw-us-house-20022265-25
disclosureDate2023-01-20
transactionDate2022-12-12
transactionTypeP